Hereditary cancer and cancer genetics
Assessing your risk/genetic counseling
Application of breast
cancer risk prediction models in clinical practice
Susan M. Domchek, Andrea Eisen, Kathleen Calzone, Jill Stopfer, Anne Blackwood,
Barbara L. Weber Journal of Clinical Oncology.
Volume 21, Issue 4, p. 593-601, February, 2003.
Breast
cancer risk assessment models: applicability to African-American women
Melissa L. Bondy, Ph.D., Lisa A. Newman, M.D Cancer.
Volume 97, Issue S1, p. 236-245, December 2002.
Clinical characteristics
of individuals with germline mutations in BRCA1 and BRCA2: analysis of
10,000 ndividuals
Thomas S. Frank, Amie M. Deffenbaugh, Julia E. Reid, Mark Hulick, Brian E.
Ward, Beth Lingenfelter, Kathi L. Gumpper, Thomas Scholl, Sean V. Tavtigian,
Dmitry R. Pruss, Gregory C. Critchfield. Journal
of Clinical Oncology. Volume 20, Issue 6: p. 1480-1490, March 2002.
Limitations
of the Gail Model in the ppecialized breast cancer risk assessment clinic
David M. Euhus, MD, A. Marilyn Leitch, MD, James F. Huth, MD, and George
N. Peters, MD. The Breast Journal. Volume 8
Issue 1: p 23, January/February 2002.
Understanding
mathematical models for breast cancer risk assessment and counseling
David M. Euhus, MD. The Breast Journal. Volume
7, Issue 4: p. 224, July 2001.
(A literature review)
The
effectiveness of the Gail Model in estimating risk for development of breast
cancer in women under 40 years of age
Gasan Mackarem, MD, Constance A. Roche, MSN, RN, CS, and Kevin S. Hughes,
MD. The Breast Journal. Volume 7, Issue 1:
p. 34-39, January 2001.